Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney

A 55-year-old man with a solitary kidney was diagnosed with an 8.5 cm renal cell carcinoma in the right kidney without metastasis. Twenty five months of sunitinib treatment reduced the tumor from 8.5 to 5.5 cm and enabled nephron-sparing surgery. He has no evidence of recurrence 58 months after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tochigi, Kosuke, Funahashi, Yasuhito, Mori, Aya, Matsukawa, Yoshihisa, Kato, Masashi, Gotoh, Momokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556451/
https://www.ncbi.nlm.nih.gov/pubmed/31239602
http://dx.doi.org/10.18999/nagjms.81.2.337
_version_ 1783425327142273024
author Tochigi, Kosuke
Funahashi, Yasuhito
Mori, Aya
Matsukawa, Yoshihisa
Kato, Masashi
Gotoh, Momokazu
author_facet Tochigi, Kosuke
Funahashi, Yasuhito
Mori, Aya
Matsukawa, Yoshihisa
Kato, Masashi
Gotoh, Momokazu
author_sort Tochigi, Kosuke
collection PubMed
description A 55-year-old man with a solitary kidney was diagnosed with an 8.5 cm renal cell carcinoma in the right kidney without metastasis. Twenty five months of sunitinib treatment reduced the tumor from 8.5 to 5.5 cm and enabled nephron-sparing surgery. He has no evidence of recurrence 58 months after the surgery.
format Online
Article
Text
id pubmed-6556451
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nagoya University
record_format MEDLINE/PubMed
spelling pubmed-65564512019-06-25 Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney Tochigi, Kosuke Funahashi, Yasuhito Mori, Aya Matsukawa, Yoshihisa Kato, Masashi Gotoh, Momokazu Nagoya J Med Sci Case Report A 55-year-old man with a solitary kidney was diagnosed with an 8.5 cm renal cell carcinoma in the right kidney without metastasis. Twenty five months of sunitinib treatment reduced the tumor from 8.5 to 5.5 cm and enabled nephron-sparing surgery. He has no evidence of recurrence 58 months after the surgery. Nagoya University 2019-05 /pmc/articles/PMC6556451/ /pubmed/31239602 http://dx.doi.org/10.18999/nagjms.81.2.337 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Tochigi, Kosuke
Funahashi, Yasuhito
Mori, Aya
Matsukawa, Yoshihisa
Kato, Masashi
Gotoh, Momokazu
Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney
title Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney
title_full Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney
title_fullStr Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney
title_full_unstemmed Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney
title_short Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney
title_sort pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556451/
https://www.ncbi.nlm.nih.gov/pubmed/31239602
http://dx.doi.org/10.18999/nagjms.81.2.337
work_keys_str_mv AT tochigikosuke presurgicalsunitinibtreatmentenablingnephronsparingsurgeryinapatientwithrenalcellcarcinomainasolitarykidney
AT funahashiyasuhito presurgicalsunitinibtreatmentenablingnephronsparingsurgeryinapatientwithrenalcellcarcinomainasolitarykidney
AT moriaya presurgicalsunitinibtreatmentenablingnephronsparingsurgeryinapatientwithrenalcellcarcinomainasolitarykidney
AT matsukawayoshihisa presurgicalsunitinibtreatmentenablingnephronsparingsurgeryinapatientwithrenalcellcarcinomainasolitarykidney
AT katomasashi presurgicalsunitinibtreatmentenablingnephronsparingsurgeryinapatientwithrenalcellcarcinomainasolitarykidney
AT gotohmomokazu presurgicalsunitinibtreatmentenablingnephronsparingsurgeryinapatientwithrenalcellcarcinomainasolitarykidney

Ejemplares similares